Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001373604-25-000063·BML Investment Partners, L.P.
Schedule 13D ownership disclosure
ESSA PHARMA INC
Common Shares · CUSIP: 29668H708
Event date: 2025-04-24
- Filing-level shares
- 4,221,546
- Percent of class
- 9.5%
- BML Investment Partners, L.P.Reported CIK 0001373604
Shares: 4,221,546 · Class: 9.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000063
- Form type
- SCHEDULE 13D
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Apr 24, 2025
- Reporting period
- Apr 24, 2025
- Description
- Schedule 13D beneficial ownership